|
Fondaparinux Sodium System Suitability Mixture B Solution |
114870-03-0 (major component) |
1282742 |
USP |
詳細を見る
|
|
Fluphenazine Decanoate N4-oxide (15 mg) |
76005-64-6 |
1280804 |
USP |
詳細を見る
|
|
Fesoterodine Fumarate (100 mg) |
286930-03-8 |
1269833 |
USP |
詳細を見る
|
|
Fesoterodine Chloromandelate (25 mg) |
N/A |
1269811 |
USP |
詳細を見る
|
|
Etodolac Related Compound H (25 mg) (2-(7-Ethyl-1H-indol-3-yl)ethan-1-ol) |
41340-36-7 |
1268769 |
USP |
詳細を見る
|
|
Ethyl Butyrate (1 mL) |
105-54-4 |
1265491 |
USP |
詳細を見る
|
|
Ethyl Benzoate (100 mg) |
93-89-0 |
1265479 |
USP |
詳細を見る
|
|
Eslicarbazepine Acetate Chiral Peak ID Mixture (15 mg) |
N/A |
1249519 |
USP |
詳細を見る
|
|
Eslicarbazepine Acetate Peak ID Mixture (15 mg) |
N/A |
1249520 |
USP |
詳細を見る
|
|
Eslicarbazepine Acetate (100 mg) |
236395-14-5 |
1249508 |
USP |
詳細を見る
|
